Deutsche Bank Maintains Buy on HealthEquity, Raises Price Target to $103
Portfolio Pulse from Benzinga Newsdesk
Deutsche Bank has maintained its Buy rating on HealthEquity (NASDAQ:HQY) and slightly raised the price target from $102 to $103.
September 04, 2024 | 5:23 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Deutsche Bank has reaffirmed its Buy rating on HealthEquity and increased the price target from $102 to $103, indicating a positive outlook.
The reaffirmation of a Buy rating and a slight increase in the price target by Deutsche Bank suggests confidence in HealthEquity's performance, likely leading to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100